Under terms of the deal, CSPC will receive $110 million upfront, with potential milestone payments reaching up to $5.22 ...

Rachel Reeves’s tax raid pulled in £300m less than expected during its first two months of operation, the Office for Budget ...

AstraZeneca signed a potential $5 billion research deal with Chinese drugmaker CSPC. Eli Lilly is buying Verve Therapeutics for $1 billion upfront plus a CVR potentially worth another $300 million.

London’s FTSE 100 faded into the close on Friday, ending lower, as weak retail sales data and falls in heavyweight oil and ...

(Alliance News) - London's FTSE 100 is called to open higher, while the dollar and Brent fell as US President Donald Trump announced a ceasefire in the Iran-Israel conflict. Trump said a ceasefire ...

Since BlackRock’s appointment as Investment Manager on 1 April 2012. 4 Further details are given in the Glossary in the Half Yearly Financial Report. Equity market investors sought alternative assets ...

London Tech Week showcased the UK's AI acumen, backed by £1bn of government funding. But digital infrastructure needs critical attention.

Though threatened, new drug discoveries are still an American advantage A decade ago, China had just a few hundred pharmaceutical drugs actively in development. Today, China has thousands of drugs in ...

Interest rate speculation and Middle East uncertainty today held back European markets during a lacklustre session for the ...

AstraZeneca has put more than $1 billion in biobucks into a series of artificial intelligence partnerships over the past few years. In the basement of Chicago’s McCormick Place, in the spooky, cubicle ...